Evidence map›Paper›PMID 21775459›Full record

ArticleJournal of virology2011

Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.

Kai A Kropp, Kevin A Robertson, Garwin Sing, Sara Rodriguez-Martin, Mathieu Blanc, Paul Lacaze, Muhamad F B Noor Hassim, Mizanur R Khondoker, Andreas Busche, Paul Dickinson and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cytomegalovirus memory inflation and immune protection.Medical microbiology and immunology · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Kai A KroppDivision of Pathway Medicine, University of Edinburgh Medical School, Edinburgh, UK.
Kevin A Robertson
Garwin Sing
Sara Rodriguez-Martin
Mathieu Blanc
Paul Lacaze
Muhamad F B Noor Hassim
Mizanur R Khondoker
Andreas Busche
Paul Dickinson
Thorsten Forster
Birgit Strobl
Mathias Mueller
Stipan Jonjic
Ana Angulo
Peter Ghazal
University of Edinburgh · GBUniversity of Veterinary Medicine Vienna · ATMedizinische Hochschule Hannover · DEConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversity of Rijeka · HR

Funding

Viral evasion of NK cellsR01AI083201 · NIAID · UNIVERSITY OF RIJEKA--MEDICAL FACULTY · PI JONJIC, STIPAN · 2009 to 2012
$331k
Biotechnology and Biological Sciences Research Council BB/D019621/1Biotechnology and Biological Sciences Research Council R36269NIAID NIH HHS R01 AI083201Wellcome Trust WT066784/Z/02/Z
6 · The paper itself

Abstract

Activated macrophages play a central role in controlling inflammatory responses to infection and are tightly regulated to rapidly mount responses to infectious challenge. Type I interferon (alpha/beta interferon [IFN-α/β]) and type II interferon (IFN-γ) play a crucial role in activating macrophages and subsequently restricting viral infections. Both types of IFNs signal through related but distinct signaling pathways, inducing a vast number of interferon-stimulated genes that are overlapping but distinguishable. The exact mechanism by which IFNs, particularly IFN-γ, inhibit DNA viruses such as cytomegalovirus (CMV) is still not fully understood. Here, we investigate the antiviral state developed in macrophages upon reversible inhibition of murine CMV by IFN-γ. On the basis of molecular profiling of the reversible inhibition, we identify a significant contribution of a restricted type I IFN subnetwork linked with IFN-γ activation. Genetic knockout of the type I-signaling pathway, in the context of IFN-γ stimulation, revealed an essential requirement for a primed type I-signaling process in developing a full refractory state in macrophages. A minimal transient induction of IFN-β upon macrophage activation with IFN-γ is also detectable. In dose and kinetic viral replication inhibition experiments with IFN-γ, the establishment of an antiviral effect is demonstrated to occur within the first hours of infection. We show that the inhibitory mechanisms at these very early times involve a blockade of the viral major immediate-early promoter activity. Altogether our results show that a primed type I IFN subnetwork contributes to an immediate-early antiviral state induced by type II IFN activation of macrophages, with a potential further amplification loop contributed by transient induction of IFN-β.

Indexed as

AnimalsInterferon-gammaInterferon Type IMacrophage ActivationMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLMuromegalovirusSignal TransductionTime FactorsInterferon-gammaInterferon Type I

Identifiers

PMID21775459
PMCPMC3196417
OpenAlexW2155556851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.